ArticleJournal of immigrant and minority health2025
The Interconnected Issue of Antimicrobial Resistance Due to Social Inequalities Worldwide.
Article in Journal of immigrant and minority health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Codesigned Approach to Develop Tailored Antimicrobial Stewardship Strategies in Bangladesh: A Social-Ecological Systems Framework Analysis.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Sputum antimicrobial susceptibility patterns and clinical outcomes among adult Aboriginal Australians with bronchiectasis.Therapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is an escalating global health threat, exacerbated by significant social inequalities. While inappropriate antibiotic use is a known driver, socioeconomic factors such as poverty, limited access to healthcare, and poor living conditions play a crucial role in the emergence and spread of resistant pathogens, particularly in low- and middle-income countries. Disadvantaged populations often resort to self-medication or substandard drugs, contributing to resistance development. This complex interplay calls for a systemic, cross-sectoral response rooted in the One Health and Planetary Health frameworks, recognizing social inequality as a key determinant of AMR. Effective action requires equitable access to quality healthcare, sustainable food systems, improved sanitation, and environmental policies addressing pharmaceutical pollution. Only through coordinated global efforts can we mitigate the rise of AMR and protect both human Q1 and planetary health.
Indexed as
Identifiers
40464870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.